Skip to main content
. 2024 Jun 28;12(4):e1230. doi: 10.1002/prp2.1230

FIGURE 2.

FIGURE 2

(A) Reconstructed ion chromatograms displaying the unchanged drug and its metabolites from LC–MS/MS analysis following 1‐h incubation of 10 μM of ELP‐004 in NADPH, NADH, UDPGA, DTT, PAPS fortified liver S9 from human (HL, left), and mouse (ML, right). (B) In vitro metabolic pathways of ELP‐004 in human and mouse.